Rosetta Genomics' Shareholders OK Reverse Stock Split | GenomeWeb

Rosetta Genomics' Shareholders OK Reverse Stock Split

May 14, 2012

|

a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics today said that its shareholders have approved a one-for-fifteen reverse stock split, which will take effect before trading opens Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Related Articles

Jun 30, 2014

Seeking Nasdaq Listing, WaferGen Effects One-for-10 Reverse Stock Split

Feb 04, 2015

Genetic Technologies Regains Compliance with Nasdaq Listing Requirement, Works to Meet Another Requirement

Jun 25, 2014

Nasdaq Tells Response Genetics it May Face Delisting of Shares

Sep 22, 2014

Nanosphere Receives Deficiency Letter from Nasdaq

Feb 02, 2015

BG Medicine Granted Continued Listing on Nasdaq as It Works Towards Meeting Requirements

Dec 01, 2014

Nasdaq Issues Second Warning to BG Medicine on Listing Requirement